Phase I Trial of Ifosfamide and 24-h Infusional Paclitaxel in Pelvic Malignancies: A Gynecologic Oncology Group Study

Author： Markman M. Spriggs D. Burger R.A. Carson L.F. Lentz S.S. Gallion H.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.80, Iss.3, 2001-03, pp. : 359-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G. Blessing J.A. Ball H.

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite

Lack of Efficacy of 24-h Infusional Topotecan in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Trial

By Markman M. Blessing J.A. DeGeest K. Morgan M. Look K.Y. Herzog T.J. Rose P.G.

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 444-446

Elsevier

Access to resources Recommend Favorite

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G. Brunetto V.L. Kilgore L. Soper J.T. McGehee R. Olt G. Lentz S.S. Sorosky J. Hsiu J.-G.

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study

By Ball H.G. Blessing J.A. Lentz S.S. Mutch D.G.

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 278-281

Academic Press

Access to resources Recommend Favorite

A Phase II Gynecologic Oncology Group Trial of Ifosfamide and Mesna in Advanced or Recurrent Adenocarcinoma of the Endometrium

By Sutton G.P. Blessing J.A. deMars L.R. Moore D. Burke T.W. Grendys E.C.

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 25-27

Academic Press

Access to resources Recommend Favorite